 | Lexicon Pharmaceuticals (NASDAQ:LXRX) Shares Gap Up to $5.07
americanbankingnews.com - April 13 at 11:10 AM |
 | Lexicon Pharmaceuticals to Participate in the 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 8 at 6:01 PM |
| Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Short Interest Update
americanbankingnews.com - April 2 at 1:08 AM |
| Lexicon Pharmaceuticals (NASDAQ:LXRX) versus Crinetics Pharmaceuticals (NASDAQ:CRNX) Financial Review
americanbankingnews.com - March 30 at 2:36 PM |
| Lexicon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:LXRX)
americanbankingnews.com - March 30 at 8:44 AM |
| Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Given Average Rating of "Hold" by Analysts
americanbankingnews.com - March 28 at 2:48 AM |
| Investors Buy High Volume of Lexicon Pharmaceuticals Call Options (NASDAQ:LXRX)
americanbankingnews.com - March 25 at 6:38 AM |
| Implied Volatility Surging for Lexicon Pharmaceuticals (LXRX) Stock Options
finance.yahoo.com - March 15 at 1:49 PM |
 | Lexicon Pharmaceuticals, Inc. (LXRX) CEO Lonnel Coats on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - March 12 at 3:20 PM |
| Lexicon: Q4 Earnings Snapshot
finance.yahoo.com - March 10 at 6:47 PM |
|
| Lexicon Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Clinical Update
finance.yahoo.com - March 10 at 6:47 PM |
 | Earnings Preview: Lexicon Pharmaceuticals
benzinga.com - March 9 at 2:08 PM |
| Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2020 Financial Results Conference Call and Webcast on March 10, 2021
finance.yahoo.com - March 4 at 6:53 PM |
| Lexicon's Sotagliflozin: New Approach To Safety May Make Approval Easier
seekingalpha.com - March 2 at 11:33 AM |
| Sarepta (SRPT) Q4 Loss Widens Y/Y, Revenues Beat Estimates
finance.yahoo.com - March 2 at 11:33 AM |
| Perrigo (PRGO) Misses on Q4 Earnings, to Sell Generic Unit
finance.yahoo.com - March 1 at 12:36 PM |
| Repligen (RGEN) to Report Q4 Earnings: What's in the Cards?
finance.yahoo.com - February 11 at 12:59 PM |
 | Should You Buy Lexicon Pharmaceuticals Stock?
fool.com - February 6 at 6:58 AM |
| News Flash: Analysts Just Made An Incredible Upgrade To Their Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Forecasts
finance.yahoo.com - January 31 at 12:39 PM |
| Got $5,000 and 5 Years to Wait? Buy These 5 Hot Biotech Stocks Now
finance.yahoo.com - January 29 at 8:25 AM |
| Why Lexicon Pharmaceuticals Stock Is Down Today
fool.com - January 16 at 1:35 AM |
| Lexicon (LXRX) Soars on FDA Permission for Sotagliflozin NDA
finance.yahoo.com - January 15 at 11:43 AM |
 | FDA Expands Approved Use Of PFE's Xalkori, LXRX Soars On Sotagliflozin Update, BCYC Hits New High
nasdaq.com - January 15 at 1:21 AM |
 | Why Lexicon Pharma's Stock Is Surging Higher Today
msn.com - January 14 at 8:20 PM |
| Why Lexicon Pharmaceuticals Stock Doubled and Then Some on Thursday
msn.com - January 14 at 8:20 PM |
 | Mid-Day Market Update: Volt Information Sciences Drops After Q4 Results; Lexicon Pharmaceuticals Shares Jump
markets.businessinsider.com - January 14 at 3:17 PM |
| Is Lexicon Pharma a Stock to Buy After 90% Runup and FDA Nod?
msn.com - January 14 at 3:17 PM |
| Stock Alert: Lexicon Pharmaceuticals Surges 35%
nasdaq.com - January 14 at 3:17 PM |
| Lexicon Pharmaceuticals and NantKwest among healthcare gainers; Cassava Sciences among losers
seekingalpha.com - January 14 at 11:43 AM |
| Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure
finance.yahoo.com - January 14 at 9:37 AM |
|
| Lexicon Pharmaceuticals to Participate in the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 6 at 12:23 PM |
| Lexicon (LXRX) Starts Dosing in Post-Herpetic Neuralgia Study
finance.yahoo.com - January 4 at 12:36 PM |
| Lexicon Pharma Kicks Off Dosing In Phase 2 Study Of Post-Herpetic Neuralgia Treatment
nasdaq.com - January 1 at 8:25 AM |
| Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia
finance.yahoo.com - December 31 at 1:47 PM |
| Moving Average Crossover Alert: Lexicon Pharmaceuticals (LXRX)
finance.yahoo.com - December 31 at 7:53 AM |
| Lexicon Pharma Inks Data Collaboration Deal With AC Bioscience
nasdaq.com - December 17 at 1:45 PM |
| After Hours Market: Wunong Net, Lexicon Pharma, Scopus BioPharma Gain; Upstart Holdings Slips
markets.businessinsider.com - December 16 at 5:08 PM |
| Lexicon Pharmaceuticals Enters Data Collaboration With AC Bioscience
finance.yahoo.com - December 16 at 5:08 PM |
| Lexicon Buoyed By Renewed Enthusiasm For The Pipeline
seekingalpha.com - December 15 at 6:20 PM |
| Is LXRX A Good Stock To Buy Now?
finance.yahoo.com - December 12 at 7:23 PM |
| Why Lexicon Pharmaceuticals Flopped on Friday
fool.com - December 11 at 6:15 PM |
| Lexicon Pharma: LX9211 Receives Fast Track Designation - Quick Facts
nasdaq.com - December 11 at 12:22 PM |
| Lexicon Pharmaceuticals Receives Fast Track Designation From the FDA for LX9211 for Diabetic Peripheral Neuropathic Pain
finance.yahoo.com - December 11 at 12:22 PM |
| Lexicon Announces Offering of Common Stock
finance.yahoo.com - December 11 at 12:22 PM |
| Is the Options Market Predicting a Spike in Lexicon Pharmaceuticals (LXRX) Stock?
finance.yahoo.com - December 9 at 6:06 PM |
| Why Lexicon Pharmaceuticals's Stock is Up During Today's Session
benzinga.com - December 8 at 4:05 PM |
 | Thinking about buying stock in Tesla, FuelCell Energy, Lexicon Pharmaceuticals, Electrameccanica Vehicles, or Outlook Therapeutics?
marketwatch.com - November 17 at 6:07 PM |
| Why Lexicon Pharmaceuticals Stock Is Trading Higher Today
feeds.benzinga.com - November 17 at 11:30 AM |
| 41 Stocks Moving in Tuesday's Pre-Market Session
msn.com - November 17 at 8:00 AM |
| Lexicon Pharma +45% after drug shows benefits for heart patients
seekingalpha.com - November 17 at 8:00 AM |
